Mark A. Hallman, MD, PhD, Joins Fox Chase Cancer Center’s Department of Radiation Oncology

PHILADELPHIA, PA (August 19, 2014)—Mark A. Hallman, MD, PhD, has joined Fox Chase Cancer Center’s Department of Radiation Oncology. He completed his residency in radiation oncology this June at Fox Chase, having served as chief resident.

Dr. Hallman’s primary area of focus is the treatment of patients with thoracic, hematologic, and genitourinary malignancies. He has extensive training in several specialized radiation techniques, including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and prostate brachytherapy.

“While knowledge and expertise are important, I believe that compassion and personalized care are also essential to being an effective physician,” said Dr. Hallman. “I strive to establish trust and understanding with my patients in order to best help them complete complex and intense cancer therapies in order to achieve the best possible outcomes.”

Dr. Hallman received his medical degree as well as a doctorate in cell and molecular pharmacology and experimental therapeutics from the Medical University of South Carolina in Charleston.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text